- Home
- LXEO vs FONR Comparison
LXEO vs FONR Comparison
Compare LXEO & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- FONR
- Stock Information
- Founded
- LXEO 2017
- FONR 1978
- Country
- LXEO United States
- FONR United States
- Employees
- LXEO N/A
- FONR N/A
- Industry
- LXEO
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LXEO
- FONR Health Care
- Exchange
- LXEO Nasdaq
- FONR Nasdaq
- Market Cap
- LXEO 93.9M
- FONR 77.1M
- IPO Year
- LXEO 2023
- FONR 1987
- Fundamental
- Price
- LXEO $4.65
- FONR $15.77
- Analyst Decision
- LXEO Strong Buy
- FONR
- Analyst Count
- LXEO 5
- FONR 0
- Target Price
- LXEO $16.60
- FONR N/A
- AVG Volume (30 Days)
- LXEO 435.8K
- FONR 32.6K
- Earning Date
- LXEO 08-11-2025
- FONR 05-15-2025
- Dividend Yield
- LXEO N/A
- FONR N/A
- EPS Growth
- LXEO N/A
- FONR N/A
- EPS
- LXEO N/A
- FONR 1.28
- Revenue
- LXEO N/A
- FONR $103,018,089.00
- Revenue This Year
- LXEO N/A
- FONR N/A
- Revenue Next Year
- LXEO N/A
- FONR N/A
- P/E Ratio
- LXEO N/A
- FONR $12.47
- Revenue Growth
- LXEO N/A
- FONR 0.29
- 52 Week Low
- LXEO $1.45
- FONR $12.00
- 52 Week High
- LXEO $13.63
- FONR $18.64
- Technical
- Relative Strength Index (RSI)
- LXEO 61.04
- FONR 54.41
- Support Level
- LXEO $3.60
- FONR $15.85
- Resistance Level
- LXEO $4.31
- FONR $16.22
- Average True Range (ATR)
- LXEO 0.33
- FONR 0.30
- MACD
- LXEO -0.00
- FONR -0.08
- Stochastic Oscillator
- LXEO 71.95
- FONR 2.60
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.